Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile

NCT02949752 is registered in ClinicalTrials.gov with Institute of Mental Health, Singapore as lead sponsor.

NCT NCT02949752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02949752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
Lead sponsor
Institute of Mental Health, Singapore
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2016
Completion date
January 1, 2020
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antipsychotics weight gain